Theriva Biologics TOVX Cash Flow Statement (2010-2026)

NYSE TOVX
$0.24 +0.01 (+4.35%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-3.41M-5.34M-4.27M-4.48M-4.49M-7.87M-4.48M-5.08M-3.30M-6.59M-5.17M-8.32M-7.73M-4.45M-4.32M-13.06M-4.36M-2.00M-2.04M-3.22M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
0.10M0.11M0.11M0.12M0.13M0.13M0.15M0.14M0.14M0.16M0.17M0.18M0.16M0.10M0.17M0.23M0.15M0.14M0.69M
Gains from Investment Securities (Quarter)
0.43M0.23M2.33M0.14M0.43M-1.57M1.11M0.20M-0.28M0.59M0.18M0.02M9.15M0.63M-0.78M0.03M-0.21M
Asset Writedowns and Impairment (Quarter)
4.10M1.30M
Cash from Operations (Quarter)
-2.16M-4.81M-4.90M-4.36M-4.46M-5.37M-5.61M-3.89M-2.95M-6.54M-4.88M-3.45M-3.91M-4.69M-4.76M-4.71M-4.32M-2.88M-2.46M-3.08M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
4.10M1.50M0.01M
Depreciation & Amortization (CF) (Quarter)
0.02M0.01M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.04M0.04M0.04M0.03M0.03M0.03M0.03M0.03M0.03M0.02M0.02M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)
0.69M-0.73M0.01M-0.31M-0.21M0.12M-0.44M0.26M0.11M-0.08M-0.19M0.37M-0.20M0.14M-0.44M0.14M0.16M0.21M-0.40M0.39M
Change in Accured Expenses (Quarter)
0.22M0.03M-0.65M0.91M0.01M-0.54M-0.76M1.09M-0.46M1.60M0.38M-0.92M1.26M-1.07M0.29M-0.72M-0.96M0.64M-0.17M0.37M
Other Working Capital Changes (Quarter)
-0.05M-0.05M-0.05M-0.05M-0.03M0.00M-0.10M-0.10M-0.11M-0.11M-0.12M-0.12M-0.12M-0.12M-0.13M-0.14M-0.14M-0.15M-0.16M-0.12M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.01M0.09M0.01M0.01M0.13M0.06M0.02M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
3.86M
Cash from Investing Activities (Quarter)
-4.28M-0.01M-0.01M-0.09M-0.01M-0.01M-0.13M-0.06M-0.02M
Financing Activities
Other financing activities (Quarter)
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
1.40M0.06M0.03M0.01M
Long-Term Debt Repayments (Quarter)
1.38M0.06M0.02M0.06M
Short-Term Debt issuances (Quarter)
-0.06M-0.01M-0.00M-0.00M-0.05M-0.01M
Change in Capital Stock
Shares Issued (Quarter)
2.45M0.63M6.11M0.61M0.24M0.09M2.30M0.20M2.28M0.18M4.18M4.17M0.18M0.18M0.01M0.01M0.01M1.11M0.65M2.58M
Net Equity Issued and Repurchased (Quarter)
0.00M1.80M1.65M0.28M0.11M
Misc.
Cash from Financing Activities (Quarter)
-1.38M2.73M-3.29M-0.06M2.14M0.00M-1.46M3.72M0.01M3.07M6.81M-0.15M8.46M3.87M-0.01M
Exchange Rate Effect (Quarter)
0.03M-0.06M-0.05M0.05M-0.04M-0.06M-0.01M0.08M-0.04M0.01M0.02M-0.12M0.09M-0.03M-0.11M-0.05M-0.04M0.01M
Change in Cash (Quarter)
-2.16M-4.81M-10.53M-4.43M-1.78M-8.66M-5.71M-1.83M-3.09M-7.98M-4.92M-1.67M-0.18M-4.81M-1.59M2.05M-4.59M5.53M1.37M-3.10M
Free Cash Flow (Quarter)
-2.16M-4.81M-4.90M-4.37M-4.47M-5.46M-5.62M-3.90M-3.08M-6.60M-4.88M-3.45M-3.91M-4.69M-4.76M-4.71M-4.34M-2.88M-2.46M-3.08M
Net Cash Flow (Quarter)
-2.16M-4.81M-10.56M-4.37M-1.73M-8.75M-5.67M-1.76M-3.08M-8.05M-4.88M-3.45M-0.20M-4.68M-1.68M2.10M-4.49M5.58M1.41M-3.10M